Associations between interarm differences in blood pressure and cardiovascular disease outcomes: protocol for an individual patient data meta-analysis and development of a prognostic algorithm

被引:5
|
作者
Clark, Christopher E. [1 ]
Boddy, Kate [2 ]
Warren, Fiona C. [1 ]
Taylor, Rod S. [1 ]
Aboyans, Victor [3 ,4 ]
Cloutier, Lyne [5 ]
McManus, Richard J. [6 ]
Shore, Angela C. [7 ,8 ]
Campbell, John L. [1 ]
机构
[1] Univ Exeter, Sch Med, Inst Hlth Serv Res, Primary Care Res Grp, Exeter, Devon, England
[2] Univ Exeter, Sch Med, PenCLAHRC, Patient & Publ Involvement Team, Exeter, Devon, England
[3] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France
[4] INSERM 1098, Trop Neuroepidemiol, Limoges, France
[5] Univ Quebec A Trois Rivieres, Dept Sci Infirmieres, Trois Rivieres, PQ, Canada
[6] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[7] Royal Devon & Exeter Hosp, NIHR Exeter Clin Res Facil, Exeter, Devon, England
[8] Univ Exeter, Med Sch, Exeter, Devon, England
来源
BMJ OPEN | 2017年 / 7卷 / 06期
基金
美国国家卫生研究院;
关键词
PRIMARY-CARE; PARTICIPANT DATA; GENERAL-PRACTICE; RISK-FACTORS; ARM; MORTALITY; PREVALENCE; HYPERTENSION; VALIDATION; MODEL;
D O I
10.1136/bmjopen-2017-016844
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Individual cohort studies in various populations and study-level meta-analyses have shown interarm differences (IAD) in blood pressure to be associated with increased cardiovascular and all-cause mortality. However, key questions remain, such as follows: (1) What is the additional contribution of IAD to prognostic risk estimation for cardiovascular and all-cause mortality? (2) What is the minimum cut-off value for IAD that defines elevated risk? (3) Is there a prognostic value of IAD and do different methods of IAD measurement impact on the prognostic value of IAD? We aim to address these questions by conducting an individual patient data (IPD) meta-analysis. Methods and analysis This study will identify prospective cohort studies that measured blood pressure in both arms during recruitment, and invite authors to contribute IPD datasets to this collaboration. All patient data received will be combined into a single dataset. Using one-stage meta-analysis, we will undertake multivariable time-to-event regression modelling, with the aim of developing a new prognostic model for cardiovascular risk estimation that includes IAD. We will explore variations in risk contribution of IAD across predefined population subgroups (eg, hypertensives, diabetics), establish the lower limit of IAD that is associated with additional cardiovascular risk and assess the impact of different methods of IAD measurement on risk prediction. Ethics and dissemination This study will not include any patient identifiable data. Included datasets will already have ethical approval and consent from their sponsors. Findings will be presented to international conferences and published in peer reviewed journals, and we have a comprehensive dissemination strategy in place with integrated patient and public involvement.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Prognostic factors and surgical outcomes of foot drop secondary to lumbar degenerative disease: A systematic review and Individual patient data meta-analysis
    Baig Mirza, Asfand
    Khizar Khoja, Abbas
    Naidu, Vishvan
    Ullah, Suleyman
    Plume, Jack
    Iyer, Priyanka S.
    Baig, Arsalan
    Rashed, Sami
    Fayez, Feras
    Sharma, Chaitanya
    Vastani, Amisha
    Trindade, Jandira
    Fahmy, Amr
    Serag, Ahmed
    Malik, Irfan
    Grahovac, Gordon
    Nader-Sepahi, Ali
    Bull, Jonathan
    Montgomery, Alexander
    Arvin, Babak
    Sadek, Ahmed-Ramadan
    EUROPEAN SPINE JOURNAL, 2025, : 1386 - 1397
  • [32] Outcomes following surgical interventions for hypothalamic hamartomas: protocol for a systematic review and individual patient data meta-analysis
    Goel, Keshav
    Niazi, Farbod
    Chen, Jia-Shu
    Hadjinicolaou, Aristides
    Keezer, Mark
    Gallagher, Anne
    Fallah, Aria
    Weil, Alexander G.
    BMJ OPEN, 2024, 14 (02):
  • [33] Blood pressure variability and cardiovascular disease: systematic review and meta-analysis
    Stevens, Sarah L.
    Wood, Sally
    Koshiaris, Constantinos
    Law, Kathryn
    Glasziou, Paul
    Stevens, Richard J.
    McManus, Richard J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [34] Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
    Paige, Ellie
    Barrett, Jessica
    Pennells, Lisa
    Sweeting, Michael
    Willeit, Peter
    Di Angelantonio, Emanuele
    Gudnason, Vilmundur
    Nordestgaard, Borge G.
    Psaty, Bruce M.
    Goldbourt, Uri
    Best, Lyle G.
    Assmann, Gerd
    Salonen, Jukka T.
    Nietert, Paul J.
    Verschuren, W. M. Monique
    Brunner, Eric J.
    Kronmal, Richard A.
    Salomaa, Veikko
    Bakker, Stephan J. L.
    Dagenais, Gilles R.
    Sato, Shinichi
    Jansson, Jan-Hakan
    Willeit, Johann
    Onat, Altan
    de la Camara, Agustin Gomez
    Roussel, Ronan
    Volzke, Henry
    Dankner, Rachel
    Tipping, Robert W.
    Meade, Tom W.
    Donfrancesco, Chiara
    Kuller, Lewis H.
    Peters, Annette
    Gallacher, John
    Kromhout, Daan
    Iso, Hiroyasu
    Knuiman, Matthew
    Casiglia, Edoardo
    Kavousi, Maryam
    Palmieri, Luigi
    Sundstrom, Johan
    Davis, Barry R.
    Njolstad, Inger
    Couper, David
    Danesh, John
    Thompson, Simon G.
    Wood, Angela
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (08) : 899 - 907
  • [35] Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis
    Kwak, Nakwon
    Dalcolmo, Margareth Pretti
    Daley, Charles L.
    Eather, Geoffrey
    Gayoso, Regina
    Hasegawa, Naoki
    Jhun, Byung Woo
    Koh, Won-Jung
    Namkoong, Ho
    Park, Jimyung
    Thomson, Rachel
    van Ingen, Jakko
    Zweijpfenning, Sanne M. H.
    Yim, Jae-Joon
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [36] Exploring between study heterogeneity in individual patient data meta-analysis
    Teramukai, S
    Matsuyama, Y
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 113S - 114S
  • [37] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
    Rahimi, Kazem
    LANCET, 2021, 397 (10285): : 1625 - 1636
  • [38] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
    Auer, J.
    JOURNAL FUR HYPERTONIE, 2021, 25 (02): : 40 - +
  • [39] Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data
    Thakkinstian, Ammarin
    Dmitrienko, Svetlana
    Gerbase-DeLima, Maria
    McDaniel, D. Olga
    Inigo, Pablo
    Chow, Kai Ming
    McEvoy, Mark
    Ingsathit, Atiporn
    Trevillian, Paul
    Barber, William Henry
    Attia, John
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (09) : 3017 - 3023
  • [40] Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: individual patient data meta-analysis
    Meijer, A.
    Conradi, H. J.
    Bos, E. H.
    Anselmino, M.
    Carney, R. M.
    Denollet, J.
    Doyle, F.
    Freedland, K. E.
    Grace, S. L.
    Hosseini, S. H.
    Lane, D. A.
    Pilote, L.
    Parakh, K.
    Rafanelli, C.
    Sato, H.
    Steeds, R. P.
    Welin, C.
    de Jonge, P.
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (02) : 90 - 102